SCHEMBL29608303

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O

nearest known ligand 0.55

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	C5AR1	P21730	2/20	0.55

▸	APLNR	P35414	3/20	0.51

▸	PLK1	P53350	1/20	0.48

▸	CXCR4	P61073	2/20	0.47

▸	MC4R	P32245	1/20	0.47

▸	CALCR	P30988	2/20	0.46

▸	RAMP1	O60894	1/20	0.46

▸	RAMP2	O60895	1/20	0.46

▸	RAMP3	O60896	1/20	0.46

▸	CALCRL	Q16602	1/20	0.46

▸	NPY2R	P49146	3/20	0.45

▸	NPY4R	P50391	3/20	0.45

▸	NPY5R	Q15761	3/20	0.45

▸	NPY1R	P25929	2/20	0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29606806	0.99	C5AR1 (0.54)	C5AR1APLNRPLK1CXCR4MC4R
SCHEMBL29608024	0.97	C5AR1 (0.57)	C5AR1APLNRPLK1CXCR4MC4R
SCHEMBL29608116	0.97	C5AR1 (0.57)	C5AR1APLNRPLK1CXCR4MC4R
SCHEMBL29607839	0.97	C5AR1 (0.56)	C5AR1APLNRPLK1CXCR4MC4R
SCHEMBL29607016	0.96	C5AR1 (0.56)	C5AR1APLNRPLK1CXCR4NPY2R
SCHEMBL29607498	0.96	C5AR1 (0.55)	C5AR1APLNRPLK1CXCR4CALCR
SCHEMBL29607122	0.96	C5AR1 (0.56)	C5AR1APLNRPLK1CXCR4NPY2R
SCHEMBL29607195	0.96	C5AR1 (0.56)	C5AR1APLNRPLK1CXCR4NPY2R
SCHEMBL29608118	0.93	C5AR1 (0.59)	C5AR1APLNRPLK1CXCR4
SCHEMBL29608007	0.93	C5AR1 (0.59)	C5AR1APLNRPLK1CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220120732-A1	TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES	RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL)	2022-04-21	—	—	US	disclosed